Evidence map›Paper›PMID 38567313›Full record

ArticleFrontiers in oral health2024

Enhancement of innate immunity in gingival epithelial cells by vitamin D and HDAC inhibitors.

Erika L Figgins, Payal Arora, Denny Gao, Emily Porcelli, Rabab Ahmed, Carlo Amorin Daep, Garrett Keele, Lisa K Ryan, Gill Diamond

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Extracellular cGAMP in health and disease.Molecular biomedicine · 2026
    Review
  3. The Role of Vitamin DNutrients · 2026
    Review
  4. Article
  5. Article
  6. Vitamin DInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Erika L FigginsDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, FL, United States.
Payal AroraGlobal Technology Center, Colgate Palmolive Company, Piscataway, NJ, United States.
Denny GaoDepartment of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY, United States.
Emily PorcelliDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, FL, United States.
Rabab AhmedGlobal Technology Center, Colgate Palmolive Company, Piscataway, NJ, United States.
Carlo Amorin DaepGlobal Technology Center, Colgate Palmolive Company, Piscataway, NJ, United States.
Garrett KeeleDepartment of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY, United States.
Lisa K RyanDepartment of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY, United States.
Gill DiamondDepartment of Oral Biology, University of Florida College of Dentistry, Gainesville, FL, United States.
Colgate-Palmolive (United States) · USFlorida College · USUniversity of Florida · USUniversity of Louisville · US

Funding

Initiation of immune responses to SARS COV2 in the oral cavity and upper airwayR01DE031928 · NIDCR · UNIVERSITY OF MISSISSIPPI MED CTR · PI GILL DIAMOND, SARAH C GLOVER · 2022 to 2026
$3.8M
Topical Vitamin D and Periodontal DiseaseR01DE028883 · NIDCR · UNIVERSITY OF LOUISVILLE · PI GILL DIAMOND, Keith L Kirkwood · 2021 to 2026
$3.2M
NIDCR NIH HHS R01 DE028883NIDCR NIH HHS R01 DE031928
6 · The paper itself

Abstract

Introduction: The human host defense peptide LL-37 is a component of the innate immune defense mechanisms of the oral cavity against colonization by microbes associated with periodontal disease. We have previously shown that the active form of vitamin D, 1,25(OH) Methods: We treated 3-dimensional primary cultures of GEC topically with the inactive form of vitamin D, in the presence and absence of selected histone deacetylase (HDAC) inhibitors. LL-37 mRNA levels were quantified by quantitative RT-PCR, and inhibition of invasion of bacteria was measured by fluorescence microscopy. Results: Vitamin D treatment led to an induction of LL-37 mRNA levels, as well as an inhibition of pro-inflammatory cytokine secretion. This effect was further enhanced by HDAC inhibitors, most strongly when the HDAC inhibitor, phenyl butyrate (PBA) was combined with Vitamin D Conclusions: Our results demonstrate that a combination of inactive vitamin D and sodium butyrate could be developed as a safe treatment for periodontal disease.

Indexed as

anti-inflammatoryantimicrobial peptideantiviralperiodontalvitamin D

Identifiers

PMID38567313
PMCPMC10986367
OpenAlexW4392814416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.